Cite

HARVARD Citation

    Caxaria, S. et al. (2023). Disease modification and symptom relief in osteoarthritis using a mutated GCP‐2/CXCL6 chemokine. EMBO molecular medicine. 15 (1), p. n/a. [Online]. 
  
Back to record